Here we show that functional analysis of a candidate modifier gene using a model cell line is able to provide additional evidence that SULT1A1 deletions lead to reduced risk of breast cancer in BRCA1 pathogenic variant carriers. Here, SULT1A1 is linked to breast carcinoma.